Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
The Pathogenesis of Atherosclerosis — An Update
1986 • 4,951 citations
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
1988 • 2,527 citations
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
1991 • 1,161 citations
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
1986 • 1,154 citations
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
1991 • 925 citations
Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary Arteries
1984 • 852 citations
Accelerated age-related browning of human collagen in diabetes mellitus.
1984 • 671 citations
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
1988 • 606 citations
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
1991 • 522 citations
Immunochemical detection of advanced glycosylation end products in vivo.
1992 • 496 citations
Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.
1990 • 478 citations
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
1989 • 383 citations
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.
1990 • 370 citations
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
1992 • 353 citations
Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
1992 • 261 citations
Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.
1992 • 218 citations
Post-Translational Modifications of Proteins
1993 • 217 citations
Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.
1991 • 210 citations
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
1991 • 189 citations
Replacement of Renal Function by Dialysis
1979 • 160 citations
Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.
1983 • 157 citations
Increased Vascular Permeability in Spontaneously Diabetic BB/W Rats and in Rats With Mild Versus Severe Streptozocin-Induced Diabetes: Prevention by Aldose Reductase Inhibitors and Castration
1987 • 156 citations
Endothelium-Dependent Relaxation in Aorta of BB Rat
1987 • 151 citations
Sensitivity of various visualization methods for peroxidase and alkaline phosphatase activity in immunoenzyme histochemistry
1985 • 105 citations
Albumin Permeation of New Vessels Is Increased in Diabetic Rats
1985 • 43 citations
Hyperglycemia, diabetes and vascular disease
1993 • 19 citations